Articles/ Digital/ Digital and Social Media/ Novartis/ R&D/ Views & Analysis/ Views and analysis Jay Bradner: leading Novartis into age of digitally-enabled discovery Andrew McConaghie AI, gene therapy, Jay Bradner, Novartis, pharma R&D 0 Comment Jay Bradner, head of Novartis’ drug discovery, talks to pharmaphorum about the firm’s drive to transform itself into ‘a medicine and data science company’. Share X Jay Bradner: leading Novartis into age of digitally-enabled discovery https://pharmaphorum.com/views-analysis-digital/jay-bradner-leading-novartis-age-digitally-enabled-discovery/
Articles/ R&D/ US/ Views and analysis How AI, blockchain, and big data can reduce drug development costs Linda Banks AI, big data, Blockchain, machine learning, pharma R&D 0 Comment Cutting-edge technologies are increasingly improving pharma’s R&D processes. Share X How AI, blockchain, and big data can reduce drug development costs https://pharmaphorum.com/views-and-analysis/ai-blockchain-big-data-can-reduce-drug-development-costs/
Articles/ Deep Dive/ R&D/ R&D/ Views & Analysis/ Views and analysis Pharma R&D is crying out for disruption – is AI the answer? Linda Banks AI, artificial intelligence, big data, genomics, machine learning, pharma R&D 0 Comment Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development. Share X Pharma R&D is crying out for disruption – is AI the answer? https://pharmaphorum.com/r-d/views-analysis-r-d/ai-pharma-rd-disruption/